Health Care: Drugs

Synta Pharmaceuticals Inc (SNTA: NASDAQ)

$0.343 n/a | n/a%
07/22/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 0.00 0.00 0.00 147.00K
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 0.00 0.00 147.00K
Selling, General, and Administrative Expenses 13.39M 15.75M 15.70M 11.68M
Research & Development 54.22M 68.20M 71.86M 49.41M
Operating Income before D & A (EBITDA) -67.61M -83.95M -87.56M -60.94M
Depreciation & Amortization 662.00K 673.00K 516.00K 738.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -68.27M -84.62M -88.08M -61.68M
Interest Expense 1.06M 2.21M 2.63M 1.85M
Pre-Tax Income -69.33M -86.83M -90.71M -63.53M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -68.67M -86.16M -90.19M -62.79M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -68.67M -86.16M -90.19M -62.79M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -68.67M -86.16M -90.19M -62.79M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-68.67M -86.16M -90.19M -62.79M
Preferred Dividends
Net Income Available To Common -68.67M -86.16M -90.19M -62.79M
Basic EPS from Continuing Ops. -18.55 -30.45 -44.45 -37.10
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -18.55 -30.45 -44.45 -37.10
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -18.55 -30.45 -44.45 -37.10
Basic Normalized Net Income/Share -18.55 -30.45 -44.45 -37.10
EPS fr Continuing Ops. -18.55 -30.45 -44.45 -37.10
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -18.55 -30.45 -44.45 -37.10
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -18.55 -30.45 -44.45 -37.10
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-18.55 -30.45 -44.45 -37.10
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SNTA

Latest SNTA Headlines from TheStreet

More Financial News for SNTA

Press Releases for SNTA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter